trial · primary record
Elismetrep
Acute Migraine
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 1000 |
| Primary completion | 2028-06 |
| Primary endpoint | Proportion of participants with at least one treatment-emergent adverse event (TEAE) |
| Registry ID | NCT07674654 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:38.084Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07674654
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Elismetrep · compound